News
GWLL
0.520
NaN%
--
Form 10-K: Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Press release · 22h ago
Goldenwell Biotech FY25 net loss widens to $296,471; revenue falls to $55
PUBT · 1d ago
Goldenwell Biotech Q1 FY26 net loss narrows to USD 17,606; revenue flat at no revenue
PUBT · 1d ago
Goldenwell Biotech restates September 2025-quarter net loss to USD 27,895
PUBT · 3d ago
Goldenwell Biotech restates June 2025-quarter results, posts USD 68,836 six-month net loss
PUBT · 6d ago
Goldenwell Biotech restates March-quarter net loss to USD 38,536
PUBT · 6d ago
Goldenwell Biotech says prior 10-Qs should not be relied upon ahead of restatement of legal fees
PUBT · 05/27 10:04
Goldenwell Biotech delays quarterly report filing, expects submission by May 19
PUBT · 05/12 10:08
Goldenwell Biotech delays annual report filing, targets April 15 submission
Reuters · 04/01 00:07
Weekly Report: what happened at GWLL last week (0908-0912)?
Weekly Report · 09/15/2025 10:58
Goldenwell Biotech Inc. Reports No Sales Revenue and Net Loss for Q2 2025; Earnings Per Share Remain Unchanged Due to Lack of Dilutive Items
Reuters · 09/12/2025 17:55
Weekly Report: what happened at GWLL last week (0901-0905)?
Weekly Report · 09/08/2025 10:59
Weekly Report: what happened at GWLL last week (0825-0829)?
Weekly Report · 09/01/2025 10:55
Weekly Report: what happened at GWLL last week (0818-0822)?
Weekly Report · 08/25/2025 11:05
Goldenwell Biotech Inc. Changes Auditors Amidst Going Concern Doubts
Reuters · 08/19/2025 10:30
Weekly Report: what happened at GWLL last week (0811-0815)?
Weekly Report · 08/18/2025 10:58
Goldenwell Biotech Inc. Delays Q2 Financial Report Filing, Cites Compilation Challenges
Reuters · 08/14/2025 18:49
Weekly Report: what happened at GWLL last week (0804-0808)?
Weekly Report · 08/11/2025 11:04
Weekly Report: what happened at GWLL last week (0728-0801)?
Weekly Report · 08/04/2025 11:06
More
Webull provides a variety of real-time GWLL stock news. You can receive the latest news about Goldenwell through multiple platforms. This information may help you make smarter investment decisions.
About GWLL
Goldenwell Biotech, Inc. is in the development stage whose purpose is research and development, production and sales health cares and supplements products. The Company is offering its products under two categories: Polypeptide Freeze-dried Powder and Solid Tablets Products. The Company’s products are JI MAI-Bovine Cardiac Vascular Active Peptide, Double Proline AG- three-dimensional (3D) Active Collagen Peptide, Cartilage Peptide-Type II collagen peptide, Se Plus, and Sugar Master. Bovine cardiac vascular active peptide is a protein peptide of vascular homology (amino acid type and its sequence) which made from healthy and fresh bovine cardiac vascular tissues as raw materials. Its DPAG product is designed to be an easily absorbed bioactive collagen. Type II collagen peptide is prepared from Bovine or Pig Cartilage bones by hot water extraction. Its Sugar Master product is made utilizing low temperature extraction techniques to maximize the harvest of bio-actives of plant matter.